FinancialContent is the trusted provider of stock market information to the media industry.
Latest News about Gilead Sciences Inc
Cramer's lightning round: Oil refiner Total is a winner in this environment
September 24, 2018
Cramer's lightning round: GE may have bottomed, but it's still a wait-and-see story
September 13, 2018
Stocks making the biggest move premarket: AAPL, NIO, GILD, TEVA, BMY & more
September 12, 2018
After-hours buzz: S, GILD & more
September 11, 2018
After-hours buzz: FB, F & more
July 25, 2018
Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
July 17, 2018
category Health Care/Pharmaceuticals Biotechnology and Life Sciences/Pharmaceuticals , Investing , Medical biotechnology industry , and 18 more.
category Investing/Stock Market/Stock Picks , Prudential Financial Inc , Gilead Sciences Inc , and 21 more.
Cramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects
May 10, 2018
After-hours buzz: SNAP, AAPL, GILD & more
May 01, 2018
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
April 11, 2018
Tech giants like Google and Facebook are 'ripe for the plucking,' says investor Jim Mellon
March 28, 2018
Your first trade for Thursday, February 8
February 08, 2018
category United States Steel Corp , Chicago Mercantile Exchange Holdings Inc , CME Group , and 5 more.
After-hours buzz: Snapchat, Disney and more
February 06, 2018
category Chipotle Mexican Grill Inc/ , Economics/Consumers , Akamai Technologies Inc/ , and 10 more.
category bluebird bio Inc , Health Care/Pharmaceuticals Biotechnology and Life Sciences , Business/Mergers and Acquisitions/Mergers , and 7 more.
Spark prices the first US gene therapy drug at $850,000 — which is actually less than expected
January 03, 2018
Top VC deals this week: Baidu invests in electric vehicles, Gilead buys cancer-fighting start-up
December 08, 2017
Your first trade for Tuesday, November 28
November 28, 2017
Cramer's lightning round: Step aside, Exxon. Cimarex's monster quarter was 'the best'
November 08, 2017
Gilead gains 4% after FDA approves lymphoma drug
October 18, 2017
Two patients show the promise of a historic treatment, with an equally historic price tag
September 29, 2017
category Kite Pharma Inc , Health Care/Pharmaceuticals Biotechnology and Life Sciences , Gilead Sciences Inc , and 5 more.
Your first trade for Tuesday, September 19
September 19, 2017
This year’s best-performing ETF could rise even higher
September 07, 2017
Investors are betting on a cancer cure with these stocks
August 31, 2017